John Bennett v. Itochu International Inc

572 F. App'x 80
CourtCourt of Appeals for the Third Circuit
DecidedJuly 10, 2014
Docket13-3145
StatusUnpublished
Cited by7 cases

This text of 572 F. App'x 80 (John Bennett v. Itochu International Inc) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
John Bennett v. Itochu International Inc, 572 F. App'x 80 (3d Cir. 2014).

Opinion

OPINION

HARDIMAN, Circuit Judge.

Devon Robotics, LLC, Devon Health Services, Inc., and their owner, John Bennett, M.D., appeal a post-trial judgment and a summary judgment on claims for breach of contract, breach of duty to negotiate in good faith, and promissory estop- *82 pel, and on a counterclaim for breach of contract. For the reasons that follow, we will affirm.

I

Because we write primarily for the parties, who are well acquainted with the case, we recite only the facts and procedural history essential to our decision.

This appeal arises from a soured partnership between two businessmen and their companies. In 2007, Japan-based Itochu International, Inc., began to explore investment opportunities in the United States health care industry. To that end, the head of Itochu’s enterprise division, Mounire Rabbat, became acquainted with Dr. John Bennett and his medical supply distribution company, Devon Health Services, Inc. (DHS). Rabbat and Bennett discussed two opportunities for cooperation: a multi-million dollar Itochu investment in DHS and a joint venture to sell medication-mixing robots.

The projects never materialized, and this litigation ensued. Rabbat and Bennett negotiated the DHS investment and even executed several non-binding letters of interest, but Itochu never finalized the deal. The two did come to terms on the robot-selling joint venture. Bennett formed a new company, Devon Robotics, Inc., that acquired and then leased the distribution rights for the robot to an Ito-chu subsidiary, MedSurg. A distribution agreement set out the responsibilities for both MedSurg and Devon Robotics. The joint venture failed, however. MedSurg could not sell the robot, and each side blamed the other for the failure. In the end, Devon Robotics terminated the distribution agreement with MedSurg and filed this suit in the United States District Court for the Eastern District of Pennsylvania.

Our review is limited to four claims and one counterclaim the District Court adjudicated in that suit. Devon Robotics, DHS, and Bennett brought two claims of promissory estoppel and Devon Robotics brought one claim of breach of a duty to negotiate in good faith. The District Court entered summary judgment in favor of Itochu and Rabbat on those claims. The parties went to trial on the competing claims of Devon Robotics and MedSurg for breach of the distribution agreement. After the jury returned a verdict in MedSurg’s favor, Devon Robotics, DHS, and Bennett filed this timely appeal. 1

II

A

Devon Robotics challenges the jury’s verdict on its claims for breach of the distribution agreement. After trial, Devon Robotics renewed its motion for judgment as a matter of law under Fed. R.Civ.P. 50(b), claiming that the verdict went against the weight of evidence. The District Court disagreed and denied the motion. 2 We review the District Court’s denial of Devon Robotics’s motion de novo, viewing the evidence in the light most favorable to MedSurg, as the prevailing party. See Acumed LLC v. Advanced Surgical Servs., Inc., 561 F.3d 199, 211 (3d Cir.2009). Judgment as a matter of law is appropriate when the record is “critically *83 deficient of that minimum quantity of evidence from which a jury might reasonably afford relief.” Raiczyk v. Ocean Cnty. Veterinary Hosp., 377 F.3d 266, 269 (3d Cir.2004).

Devon Robotics first alleged that Med-Surg materially breached the distribution agreement by failing to hire the contractually required minimum number of salespeople and by failing to fill certain roles. Viewing the evidence in the light most favorable to MedSurg as the verdict winner, we conclude that the jury could have reasonably found that MedSurg substantially complied with its obligations. Med-Surg introduced evidence that Devon Robotics shared in the blame for MedSurg’s incomplete sales staff, even firing two of MedSurg’s salespeople. Moreover, the jury could have reasonably found that MedSurg’s breach was not material because of evidence showing that the failure to sell robots was caused by performance problems with the robots themselves and the economic recession, which made hospitals more cost-conscious. Accordingly, the jury was entitled to conclude that Med-Surg did not materially breach its staffing obligations under the distribution agreement.

Separately, Devon Robotics argued MedSurg breached the distribution agreement by refusing to pay for a clinical trial on the robot. The jury was instructed, without objection by Devon Robotics, that MedSurg’s breach must be excused if the jury found Devon Robotics had “already decided to terminate the contract or was not acting in good faith” when MedSurg’s duty to pay ripened. App. at 1458. Med-Surg showed the jury an email, sent several days before Devon Robotics demanded payment from MedSurg, in which Bennett confirmed that Devon Robotics would terminate the distribution agreement. On that evidence alone, the jury could have reasonably found that Devon Robotics decided to terminate the distribution agreement before it billed MedSurg for the clinical trial, thus excusing MedSurg’s failure to pay. For these reasons, we perceive no error in the District Court’s dismissal of Devon Robotics’s renewed motion for judgment as a matter of law, and we will affirm its order. 3

B

Devon Robotics claims it is entitled to a new trial because of a series of questions at trial about its decision to sell a $7 million investment for $10. Its argument proceeds on two fronts: that the testimony was irrelevant under Fed.R.Evid. 401 and unfairly prejudicial under Fed.R.Evid. 403. We review evidentiary rulings for an abuse of discretion. Acumed, 561 F.3d at 211. At trial, Bennett testified that Itochu caused Devon Robotics’s financial demise. The evidence of Devon Robotics’s decision to sell $7 million in stock for $10 rebutted Dr. Bennett’s assertion, satisfying Rule 401’s relevance standard. Devon Robotics claims that the danger of unfair prejudice, confusion of the issues, and misleading the jury substantially outweighed the probative value of the evidence in contravention of Rule 403, saying only that the evidence made Appellants “appear dishonest.” Br. of Appellants at 49. We readily conclude *84 that these bare allegations fail to demonstrate an abuse of discretion and find no error in the District Court’s denial of Devon Robotics’s motion for a new trial.

For these reasons, we will affirm the order of the District Court denying Devon Robotics’s motion for a new trial.

Ill

Before trial, the District Court entered summary judgment against Devon Robotics, DHS, and Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

ZHANG v. CSL BEHRING LLC
E.D. Pennsylvania, 2024
RUGGIERO v. NOCENTI
E.D. Pennsylvania, 2021
Ecore Int'l, Inc. v. Downey
343 F. Supp. 3d 459 (E.D. Pennsylvania, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
572 F. App'x 80, Counsel Stack Legal Research, https://law.counselstack.com/opinion/john-bennett-v-itochu-international-inc-ca3-2014.